129 related articles for article (PubMed ID: 37778422)
1. Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan.
Mizumoto M; Ogino H; Okumura T; Terashima K; Murakami M; Ogino T; Tamamura H; Akimoto T; Waki T; Katoh N; Araya M; Onoe T; Takagi M; Iwata H; Numajiri H; Okimoto T; Uchinami Y; Maruo K; Shibuya K; Sakurai H
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):725-733. PubMed ID: 37778422
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.
Fukuda K; Okumura T; Abei M; Fukumitsu N; Ishige K; Mizumoto M; Hasegawa N; Numajiri H; Ohnishi K; Ishikawa H; Tsuboi K; Sakurai H; Hyodo I
Cancer Sci; 2017 Mar; 108(3):497-503. PubMed ID: 28012214
[TBL] [Abstract][Full Text] [Related]
3. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
[TBL] [Abstract][Full Text] [Related]
4. Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.
Sanford NN; Pursley J; Noe B; Yeap BY; Goyal L; Clark JW; Allen JN; Blaszkowsky LS; Ryan DP; Ferrone CR; Tanabe KK; Qadan M; Crane CH; Koay EJ; Eyler C; DeLaney TF; Zhu AX; Wo JY; Grassberger C; Hong TS
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):64-72. PubMed ID: 30684667
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
[TBL] [Abstract][Full Text] [Related]
6. Proton Beam Therapy for Intrahepatic Cholangiocarcinoma: A Multicenter Prospective Registry Study in Japan.
Mizumoto M; Terashima K; Makishima H; Suzuki M; Ogino T; Waki T; Iwata H; Tamamura H; Uchinami Y; Akimoto T; Okimoto T; Iizumi T; Murakami M; Katoh N; Maruo K; Shibuya K; Sakurai H
Liver Cancer; 2024 Apr; 13(2):161-168. PubMed ID: 38751552
[TBL] [Abstract][Full Text] [Related]
7. Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
Chadha AS; Gunther JR; Hsieh CE; Aliru M; Mahadevan LS; Venkatesulu BP; Crane CH; Das P; Herman JM; Koay EJ; Taniguchi C; Holliday EB; Minsky BD; Suh Y; Park P; Sawakuchi G; Beddar S; Odisio BC; Gupta S; Loyer E; Kaur H; Raghav K; Javle MM; Kaseb AO; Krishnan S
Radiother Oncol; 2019 Apr; 133():54-61. PubMed ID: 30935582
[TBL] [Abstract][Full Text] [Related]
8. Proton beam therapy for hepatocellular carcinoma with bile duct invasion.
Iizumi T; Okumura T; Hasegawa N; Ishige K; Fukuda K; Seo E; Makishima H; Niitsu H; Takahashi M; Sekino Y; Takahashi H; Takizawa D; Oshiro Y; Baba K; Murakami M; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
BMC Gastroenterol; 2023 Aug; 23(1):267. PubMed ID: 37537527
[TBL] [Abstract][Full Text] [Related]
9. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapy.
Mizumoto M; Oshiro Y; Okumura T; Fukuda K; Fukumitsu N; Abei M; Ishikawa H; Ohnishi K; Numajiri H; Tsuboi K; Sakurai H
Radiother Oncol; 2014 Oct; 113(1):54-9. PubMed ID: 25248924
[TBL] [Abstract][Full Text] [Related]
10. A Phase 2 Study of Image-Guided Proton Therapy for Operable or Ablation-Treatable Primary Hepatocellular Carcinoma.
Iwata H; Ogino H; Hattori Y; Nakajima K; Nomura K; Hashimoto S; Hayashi K; Toshito T; Sasaki S; Mizoe JE; Shibamoto Y
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):117-126. PubMed ID: 33798564
[TBL] [Abstract][Full Text] [Related]
11. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in breast cancer patients.
Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Okimoto T; Ogino T; Suzuki M; Murayama S
J Radiat Res; 2024 Mar; 65(2):231-237. PubMed ID: 38321606
[TBL] [Abstract][Full Text] [Related]
12. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
Sekino Y; Okumura T; Fukumitsu N; Iizumi T; Numajiri H; Mizumoto M; Nakai K; Nonaka T; Ishikawa H; Sakurai H
J Cancer Res Clin Oncol; 2020 Mar; 146(3):711-720. PubMed ID: 31776663
[TBL] [Abstract][Full Text] [Related]
13. Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis.
Kim DY; Park JW; Kim TH; Kim BH; Moon SH; Kim SS; Woo SM; Koh YH; Lee WJ; Kim CM
Radiother Oncol; 2017 Jan; 122(1):122-129. PubMed ID: 28034460
[TBL] [Abstract][Full Text] [Related]
14. Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular Carcinoma.
Cheng JY; Huang BS; Chen YY; Wang CC; Chen YH
Anticancer Res; 2023 Mar; 43(3):1361-1371. PubMed ID: 36854503
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
Hsieh CE; Venkatesulu BP; Lee CH; Hung SP; Wong PF; Aithala SP; Kim BK; Rao A; Tung-Chieh Chang J; Tsang NM; Wang CC; Lee CC; Lin CC; Tseng JH; Chou WC; Wang YC; Krishnan S; Hong JH
Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):73-86. PubMed ID: 30797890
[TBL] [Abstract][Full Text] [Related]
16. Impact of Proton Beam Irradiation of an Anatomic Subsegment of the Liver for Hepatocellular Carcinoma.
Hojo H; Raturi V; Nakamura N; Arahira S; Akita T; Mitsunaga S; Nakamura M; Motegi A; Kageyama SI; Zenda S; Okumura M; Ikeda M; Akimoto T
Pract Radiat Oncol; 2020; 10(4):e264-e271. PubMed ID: 31585204
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
18. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
[TBL] [Abstract][Full Text] [Related]
19. Longer Survival and Preserved Liver Function after Proton Beam Therapy for Patients with Unresectable Hepatocellular Carcinoma.
Nosaka T; Matsuda H; Sugata R; Akazawa Y; Takahashi K; Naito T; Ohtani M; Kinoshita K; Tsujikawa T; Sato Y; Maeda Y; Tamamura H; Nakamoto Y
Curr Oncol; 2023 Mar; 30(4):3915-3926. PubMed ID: 37185409
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma.
Yoo GS; Yu JI; Cho S; Jung SH; Han Y; Park S; Oh Y; Lee B; Park HC; Lim DH; Choi MS; Won H
Radiother Oncol; 2020 May; 146():187-193. PubMed ID: 32179362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
